Literature DB >> 27757005

Novel Treatments Target Type-2 Diabetes.

Chris Fellner.   

Abstract

Patients with type-2 diabetes can control their blood glucose levels through diet and exercise, by losing excess weight, and by taking medications, such as first-line metformin. We examine several promising drugs in the type-2 diabetes pipeline.

Entities:  

Year:  2016        PMID： 27757005      PMCID： PMC5047004     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  3 in total

1.  Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.

Authors:  Zhuang Miao; Gianluca Nucci; Neeta Amin; Raman Sharma; Vincent Mascitti; Meera Tugnait; Alfin D Vaz; Ernesto Callegari; Amit S Kalgutkar
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

Review 2.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

Review 3.  Type 2 diabetes: principles of pathogenesis and therapy.

Authors:  Michael Stumvoll; Barry J Goldstein; Timon W van Haeften
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321
  3 in total
  2 in total

Review 1.  Advances in GLP-1 treatment: focus on oral semaglutide.

Authors:  Freddy G Eliaschewitz; Luis Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2021-09-15       Impact factor: 3.320

Review 2.  Cardiovascular effects of sodium glucose cotransporter 2 inhibitors.

Authors:  Tricia Santos Cavaiola; Jeremy Pettus
Journal:  Diabetes Metab Syndr Obes       Date:  2018-04-12       Impact factor: 3.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.